Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Clover Health Investments, Corp. (CLOV:NASDAQ), powered by AI.
Clover Health Investments, Corp. is currently trading at $4.73. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Clover Health Investments, Corp. on Alpha Lenz.
Clover Health Investments, Corp.'s P/E ratio is -28.3.
“Clover Health Investments, Corp. trades at a P/E of -28.3 (undervalued) with modest ROE of -26.3%.”
Ask for details →Clover Health Investments Corp. is a next-generation healthcare technology company focusing on Medicare Advantage plans. The primary purpose of Clover Health is to democratize healthcare for seniors by utilizing advanced data analytics to improve outcomes and reduce costs. By leveraging its proprietary software platform, the Clover Assistant, the company supports healthcare providers in delivering more personalized and effective care to Medicare beneficiaries. Clover Health operates predominantly in the U.S. healthcare sector, impacting various industries including medical technology, insurance, and elder care. The company aims to streamline health services and make healthcare more accessible, emphasizing preventive care and chronic disease management. By integrating technology with healthcare, Clover Health addresses inefficiencies in traditional insurance models, positioning itself as a significant player in the evolving digital health space. As part of its market role, Clover Health represents a shift towards value-based care and reflects broader industry trends of incorporating tech-driven solutions to enhance patient care. Its approach to blending technology and healthcare aligns with the increasing demand for innovative, cost-effective health services.
“Clover Health Investments, Corp. trades at a P/E of -28.3 (undervalued) with modest ROE of -26.3%.”
Ask for details →Clover Health Investments, Corp. (ticker: CLOV) is a company listed on NASDAQ in the Healthcare sector (Healthcare Plans). It has approximately 570 employees. Market cap is $2.4B.
The current price is $4.73 with a P/E ratio of -28.31x and P/B of 7.84x.
ROE is -26.33% and operating margin is -4.44%. Annual revenue is $1.9B.